1. Action of bredinin on mammalian cells;Sakaguchi;Cancer Res,1975
2. Antitumor activities of newly synthesized 5-carbamoyl-1 H imidazol-4-yl 1-Adamantanecarboxylate and 5-carb-amoyl-1H-imidazole-4-yl piperonylate;Yoshida;Cancer Res,1980
3. Optimal treatment schedule and anti-tumor spectrum of 4-carbamoylimidazolium 5-olate (SM-108) in murinetumors;Yoshida;Cancer Res,1983
4. Antitumor imidazole derivative, 5-carbamoyl-1H-imidazole-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphorybosyltransferase;Fukui;Cancer Res,1982
5. Phase II study of SM-108 (4-carbamoylimidazolium-5-olate) on hematological malignancies;Kimura;Jpn J Cancer Chemother,1989